Palmitoyl Tripeptide-1 dosing & administration
Collagen-stimulating matrikine peptide and key component of Matrixyl 3000 for comprehensive anti-aging skin renewal.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Dosing
How much do I take?
Topical: Applied onto the skin as a cream, gel, or lotion — it works mainly where you put it.
Bioavailability Local — acts mainly at the skin; little reaches the bloodstream.
2 documented dose levels — separate regimens, not a titration schedule
Under 10 ppm (<0.001%) in finished product
Frequency
Once or twice daily
Duration
Ongoing
Up to ~0.002% in finished product
Frequency
Once or twice daily
Duration
Ongoing
Upper end of reported survey concentrations for leave-on products [6]. Even at this level the active peptide content is very low, which is normal for palmitoyl signal peptides.
Timing
Best time to take
Apply Palmitoyl Tripeptide-1 to clean, dry skin. For best results, use consistently at the same time(s) each day. Evening application is often preferred to allow overnight absorption, unless otherwise directed.
With food?
As a topical product, Palmitoyl Tripeptide-1 is not affected by food intake. Apply to clean skin and allow adequate absorption time before covering the area.
If stacking
Palmitoyl Tripeptide-1 should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting your dose
Increase if
- You've tolerated the current dose for the recommended period without significant side effects
- Therapeutic goals haven't been met at the current dose level
- Your healthcare provider recommends dose escalation based on your response
- Lab work or clinical assessments support a higher dose
Decrease if
- Side effects are bothersome or impacting daily life despite management strategies
- You experience any signs of an adverse reaction
- Lab results indicate the need for dose reduction
- Your healthcare provider recommends a lower dose based on your response
Signs of right dose
- Therapeutic goals being met with minimal side effects
- Stable and consistent response to treatment
- Lab values or clinical markers trending in the right direction
- Good tolerance with manageable or absent side effects
Administration
How do I use it?
Reconstitution
What you need
Injection
Route
Palmitoyl Tripeptide-1 is administered Topical—no injection required
Best sites
Storage
Before reconstitution
Store Palmitoyl Tripeptide-1 in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Palmitoyl Tripeptide-1 should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation — discard the vial
Sample daily schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Topical—rotate sites if applicable
Maintain a consistent schedule for optimal results with Palmitoyl Tripeptide-1. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Safety
Is it safe?
Side effects
Commonly reported: Temporary Skin Irritation, Mild Redness, Dryness, Mild Peeling
Less common: Contact Dermatitis
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Palmitoyl Tripeptide-1
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Palmitoyl Tripeptide-1 should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Flagged pairings
- High-Concentration AHAs/BHAs — Use with caution—discuss with your healthcare provider.
- Benzoyl Peroxide — Use with caution—discuss with your healthcare provider.
- Very Alkaline Products (pH >8) — Use with caution—discuss with your healthcare provider.
Published research
What the studies show
Yang F, et al. · 2024
A 12-week clinical trial of anti-aging eye cream increased skin hydration 28.12%, elasticity 18.81%, and collagen production 54.99%. Significant improvement in fine lines and wrinkles appeared by week 8.
Mortazavi SM, et al. · 2025
Topical GHK peptides including palmitoyl-GHK derivatives show promise for wrinkle prevention through tissue regeneration. Metal complexation and palmitoylation enhance penetration significantly.
He Q, et al. · 2024
No abstract available for comprehensive analysis.
Pickart L, et al. · 2018
Genetic analysis revealed GHK stimulates collagen, elastin, and glycosaminoglycan synthesis while regulating multiple repair pathways—reprogramming cells toward a younger state. Over 4,000 human genes are regulated by this single peptide.
Pickart L, et al. · 2015
GHK demonstrated natural modulation of multiple cellular pathways affecting collagen synthesis, ECM remodeling, and fibroblast vitality. The peptide tightens loose skin, improves elasticity and density, and reduces photodamage.
Johnson W et al., Cosmetic Ingredient Review (CIR) Expert Panel · 2018
CIR review of Palmitoyl Tripeptide-1 (Pal-GHK); reported survey leave-on use up to ~0.002% and customary use below 10 ppm; component of the Matrixyl 3000 blend.
Head to head
Palmitoyl Tripeptide-1 compared
Want the full picture?
The complete Palmitoyl Tripeptide-1 research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.